CV CapsoVision, Inc. - Common Stock
$6.69
Price · May 20, 2026
Fundamentals as of May 14, 2026
52W Range
$3–$15
28% of range
Analyst Rating
BUY
10 analysts
Price Target
$10
+49% upside
P/E (TTM)
-10.4
ROE
40.3%
Net Profit Margin
-186.8%
CV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.69
Market Cap
$501M
P/E (TTM)
-10.4
EPS (TTM)
$-1.03
Revenue (TTM)
$14M
Div Yield
—
ROE
40.3%
Debt/Equity
—
52W Range
$3 – $15
CV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$14M
2024-12-31
→
2025-12-31
EPS
$-1.03
2024-12-31
→
2025-12-31
Free Cash Flow
$-23M
2025-12-31
→
2025-12-31
Margins
-186.8%
2025-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CV
Peer Median
P/E (TTM)
-10.4
376.8
P/S (TTM)
37.0
6.5
P/B
37.8
4.9
Price / FCF
-21.8
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CV
Peer Median
Gross Margin
52.9%
67.3%
Operating Margin
-188.2%
—
Net Profit Margin
-186.8%
-30.7%
ROA
-144.8%
-14.1%
ROE
40.3%
-25.6%
ROIC
-192.6%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CV
Peer Median
Current Ratio
3.8
5.9
Quick Ratio
0.6
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
CV
Peer Median
Revenue YoY
15.3%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CV
Peer Median
CV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
10 analysts
- Strong Buy 3 30.0%
- Buy 6 60.0%
- Hold 1 10.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-05-16
Low
$10.00
High
$10.00
Median target
$10.00
+49.5%
Mean target
$10.00
+49.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.46%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.15 | $-0.13 | -0.02% |
| Dec. 31, 2025 | $-0.02 | $-0.15 | 0.13% |
| Sept. 30, 2025 | $-0.17 | $-0.13 | -0.04% |
| June 30, 2025 | $-2.02 | $-0.11 | -1.9% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CV | $501M | -10.4 | 15.3% | -186.8% | 40.3% | 52.9% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SI | $295M | -3.1 | 49.6% | -85.3% | -129.1% | 76.5% |
| CARL | $329M | -5.8 | 85.9% | -58.7% | -375.2% | 75.3% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 16
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $14M | $12M | |
| Cost of Revenue | $6M | $5M | |
| Gross Profit | $7M | $6M | |
| R&D Expense | $18M | $15M | |
| SG&A Expense | $7M | $4M | |
| Operating Expenses | $33M | $26M | |
| Operating Income | $-26M | $-20M | |
| Other Non-op | $-44.0K | $4.0K | |
| Pretax Income | $-25M | $-20M | |
| Income Tax | $24.0K | $11.0K | |
| Net Income | $-25M | $-20M | |
| EPS (Basic) | $-1.03 | $-9.85 | |
| EPS (Diluted) | $-1.03 | $-9.85 | |
| Shares (Basic) | 24,555,381 | 2,020,077 | |
| Shares (Diluted) | 24,555,381 | 2,020,077 | |
| EBITDA | $-25M | · |
Balance Sheet 20
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Receivables | $2M | $2M | |
| Inventory | $3M | $3M | |
| Prepaid Expense | $1M | $898.0K | |
| Other Current Assets | $448.0K | $260.0K | |
| Current Assets | $17M | $15M | |
| PP&E (Net) | $611.0K | $720.0K | |
| Accum. Depreciation | $575.0K | $359.0K | |
| Other Non-current Assets | $41.0K | $41.0K | |
| Total Assets | $18M | $17M | |
| Accounts Payable | $1M | $749.0K | |
| Accrued Liabilities | $3M | $569.0K | |
| Current Liabilities | $4M | $2M | |
| Capital Leases | $477.0K | $887.0K | |
| Total Liabilities | $5M | $3M | |
| Common Stock | $47.0K | $2.0K | |
| Paid-in Capital | $169M | $838.0K | |
| Retained Earnings | $-156M | $-130M | |
| Stockholders' Equity | $13M | $-130M | |
| Liabilities + Equity | $18M | $17M | |
| Shares Outstanding | 46,865,051 | 2,090,945 |
Cash Flow 9
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $216.0K | $206.0K | |
| Stock-based Comp | $826.0K | $156.0K | |
| Deferred Tax | $0 | $0 | |
| Other Non-cash | $1M | · | |
| Operating Cash Flow | $-23M | $-20M | |
| CapEx | $90.0K | $153.0K | |
| Investing Cash Flow | $-90.0K | $-153.0K | |
| Financing Cash Flow | $24M | $15M | |
| Free Cash Flow | $-23M | · |
Profitability 8
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 52.9% | · | |
| Operating Margin | -188.2% | · | |
| Net Margin | -186.8% | · | |
| Pretax Margin | -186.6% | · | |
| EBITDA Margin | -186.7% | · | |
| ROA | -144.8% | · | |
| ROE | 40.3% | · | |
| ROIC | -192.6% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 3.8 | · | |
| Quick Ratio | 0.6 | · |
Efficiency 3
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.8 | · | |
| Inventory Turnover | 2.3 | · | |
| Receivables Turnover | 6.0 | · |
Growth Rates 1
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 15.3% | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $14M | · | |
| Net Income TTM | $-25M | · | |
| Market Cap | $501M | · | |
| P/E | -10.4 | · | |
| P/S | 37.0 | · | |
| P/B | 37.8 | · | |
| P / Tangible Book | 37.8 | · | |
| P / Cash Flow | -21.9 | · | |
| P / FCF | -21.8 | · | |
| Earnings Yield | -9.6% | · |
Income Statement 16
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $4M | $4M | $3M | $3M | $3M | $3M | |
| Cost of Revenue | $1M | $2M | $2M | $2M | $1M | $2M | $1M | |
| Gross Profit | $1M | $2M | $2M | $2M | $1M | $2M | $2M | |
| R&D Expense | $4M | $6M | $6M | $3M | $3M | $3M | $5M | |
| SG&A Expense | $2M | $2M | $2M | $1M | $2M | $1M | $1M | |
| Operating Expenses | $8M | $9M | $10M | $6M | $7M | $6M | $7M | |
| Operating Income | $-7M | $-7M | $-8M | $-5M | $-5M | $-5M | $-6M | |
| Other Non-op | $1.0K | $0 | $-34.0K | $-11.0K | $1.0K | $2.0K | $1.0K | |
| Pretax Income | $-7M | $-7M | $-8M | $-5M | $-5M | $-5M | $-6M | |
| Income Tax | $0 | $24.0K | $0 | $0 | $0 | $11.0K | $0 | |
| Net Income | $-7M | $-7M | $-8M | $-5M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.15 | $0.02 | $-0.17 | $-2.02 | $-2.49 | $-2.20 | $-2.79 | |
| EPS (Diluted) | $-0.15 | $0.02 | $-0.17 | $-2.02 | $-2.49 | $-2.20 | $-2.79 | |
| Shares (Basic) | 47,456,908 | 7,505,710 | 46,217,127 | 2,292,230 | 2,157,627 | 26,143 | 2,076,979 | |
| Shares (Diluted) | 47,456,908 | 7,505,710 | 46,217,127 | 2,292,230 | 2,157,627 | 26,143 | 2,076,979 | |
| EBITDA | $-7M | · | $-8M | $-5M | · | · | · |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Receivables | $2M | $2M | $2M | $2M | · | $2M | · | |
| Inventory | $3M | $3M | $3M | $3M | · | $3M | · | |
| Prepaid Expense | $1M | $1M | $1M | $2M | · | $898.0K | · | |
| Other Current Assets | $527.0K | $448.0K | $373.0K | $433.0K | · | $260.0K | · | |
| Current Assets | $24M | $17M | $24M | $8M | · | $15M | · | |
| PP&E (Net) | $620.0K | $611.0K | $640.0K | $683.0K | · | $720.0K | · | |
| Accum. Depreciation | $631.0K | $575.0K | $520.0K | $466.0K | · | $359.0K | · | |
| Other Non-current Assets | $76.0K | $41.0K | $41.0K | $41.0K | · | $41.0K | · | |
| Total Assets | $26M | $18M | $26M | $10M | · | $17M | · | |
| Accounts Payable | $1M | $1M | $1M | $1M | · | $749.0K | · | |
| Accrued Liabilities | $3M | $3M | $3M | $2M | · | $569.0K | · | |
| Current Liabilities | $5M | $4M | $5M | $4M | · | $2M | · | |
| Capital Leases | $362.0K | $477.0K | $584.0K | $687.0K | · | $887.0K | · | |
| Total Liabilities | $6M | $5M | $5M | $5M | · | $3M | · | |
| Common Stock | $50.0K | $47.0K | $47.0K | $2.0K | · | $2.0K | · | |
| Paid-in Capital | $183M | $169M | $169M | $1M | · | $838.0K | · | |
| Retained Earnings | $-163M | $-156M | $-148M | $-140M | · | $-130M | · | |
| Stockholders' Equity | $20M | $13M | $20M | $-139M | · | $-130M | · | |
| Liabilities + Equity | $26M | $18M | $26M | $10M | · | $17M | · | |
| Shares Outstanding | 49,838,867 | 46,865,051 | 46,798,901 | 2,459,183 | · | 2,090,945 | · |
Cash Flow 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $56.0K | $55.0K | $54.0K | $55.0K | $52.0K | $51.0K | $52.0K | |
| Stock-based Comp | $334.0K | $197.0K | $307.0K | $170.0K | $152.0K | $113.0K | $15.0K | |
| Other Non-cash | $577.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-6M | $-8M | $-6M | $-5M | $-5M | $-5M | $-7M | |
| CapEx | $48.0K | $8.0K | $12.0K | $30.0K | $40.0K | $0 | $4.0K | |
| Investing Cash Flow | $-48.0K | $-8.0K | $-12.0K | $-30.0K | $-40.0K | $0 | $-4.0K | |
| Financing Cash Flow | $14M | $15.0K | $22M | $1M | $34.0K | $5M | $10M | |
| Free Cash Flow | $-6M | · | · | · | · | · | · |
Profitability 8
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.6% | · | 54.1% | 54.6% | · | · | · | |
| Operating Margin | -254.1% | · | -226.7% | -140.3% | · | · | · | |
| Net Margin | -251.9% | · | -223.9% | -139.5% | · | · | · | |
| Pretax Margin | -251.9% | · | -223.9% | -139.5% | · | · | · | |
| EBITDA Margin | -252.0% | · | -225.1% | -138.6% | · | · | · | |
| ROA | -54.2% | · | -61.7% | -96.9% | · | · | · | |
| ROE | -69.6% | · | -77.5% | 6.7% | · | · | · | |
| ROIC | -35.1% | · | -39.2% | 3.4% | · | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | · | 5.2 | 1.8 | · | · | · | |
| Quick Ratio | 0.4 | · | 0.4 | 0.4 | · | · | · |
Efficiency 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | · | 0.3 | 0.7 | · | · | · | |
| Inventory Turnover | 0.8 | · | 1.0 | 1.0 | · | · | · | |
| Receivables Turnover | 2.9 | · | 3.8 | 3.6 | · | · | · |
Valuation (TTM) 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | · | · | · | · | · | · | |
| Net Income TTM | $-25M | · | $-24M | $-21M | · | · | · | |
| Market Cap | $363M | · | $227M | · | · | · | · | |
| P/E | -1.5 | · | · | · | · | · | · | |
| P/S | 29.2 | · | · | · | · | · | · | |
| P/B | 18.0 | · | 11.1 | · | · | · | · | |
| P / Tangible Book | 18.0 | · | 11.1 | · | · | · | · | |
| P / Cash Flow | -59.9 | · | · | · | · | · | · | |
| P / FCF | -59.4 | · | · | · | · | · | · | |
| Earnings Yield | -66.3% | · | · | · | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Revenue | $14M | $12M |
| Gross Margin % | 52.9% | — |
| Operating Margin % | -188.2% | — |
| Net Income | $-25M | $-20M |
| Diluted EPS | $-1.03 | $-9.85 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Current Ratio | 3.8 | — |
| Quick Ratio | 0.6 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Free Cash Flow | $-23M | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.